RxDoctor Payments Data

Todd Morgan, MD

Urology · Ann Arbor, MINPI 1356452684

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (53.0%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Pfizer at 40.3% of the total. 2025 is the largest year on record at $13,612, 9.3 times the $1,466 reported in 2019. Among urology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$34,279in general payments, 2019–2025

Across 22 payments — averaging $1558.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$14K
  • Merck$8K
  • Foundation Medicine, Inc.$7K
  • Blue Earth Diagnostics$3K
  • Janssen Global Services, LLC$2K
  • Janssen Scientific Affairs, LLC$758
  • plus $822 from 4 others
$18,500in research payments, 2019–2025

Across 3 payments — averaging $6166.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Myriad Genetic Laboratories, Inc.$19K

What the payments were for

  • Consulting fees$18,18353%
  • Speaking & faculty fees$15,12044%
  • Travel & lodging$3751%
  • Food & beverage$6012%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,279 in reported general payments places this provider in the 95th percentile of 400 urology providers in Michigan.

See all urology providers in Michigan

Medicare billing

Part B allowed, 2024
$78,052
Medicare patients
186
Services billed
352

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tolterodine Tartrate ErTolterodine Tartrate12$2,185
Tamsulosin Hcl80$1,476
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst11$85
Cephalexin16$32
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$12

Paid to pharmacies, not to this prescriber.

Other urology in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →